首页|期刊导航|药物分析学报（英文）|Ginsenoside Rk2,a dehydroprotopanaxadiol saponin,alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice

Ginsenoside Rk2,a dehydroprotopanaxadiol saponin,alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice

Jian Zou Rujie Yang Ruibing Feng Jiayue Liu Jian-Bo Wan

药物分析学报（英文）2023，Vol.13Issue(9)：999-1012,14.

药物分析学报（英文）2023，Vol.13Issue(9)：999-1012,14.DOI:10.1016/j.jpha.2023.05.005

Ginsenoside Rk2,a dehydroprotopanaxadiol saponin,alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice

Jian Zou ¹Rujie Yang ¹Ruibing Feng ¹Jiayue Liu ¹Jian-Bo Wan¹

作者信息

1. State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macao SAR,China
折叠

摘要

关键词

Alcoholic liver disease/Ginsenoside Rk2/NLRP3 inflammasome/NLRP6 inflammasome/Intestinal barrier dysfunction

Key words

Alcoholic liver disease/Ginsenoside Rk2/NLRP3 inflammasome/NLRP6 inflammasome/Intestinal barrier dysfunction

引用本文复制引用

Jian Zou,Rujie Yang,Ruibing Feng,Jiayue Liu,Jian-Bo Wan..Ginsenoside Rk2,a dehydroprotopanaxadiol saponin,alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice[J].药物分析学报（英文）,2023,13(9):999-1012,14.

基金项目

The work was financially supported by grants from the Research Committee of the University of Macau(Grant No.:MYRG2022-00020-ICMS),and the Science and Technology Development Fund,Macao SAR,China(File No.:0074/2021/AFJ and 0052/2022/A1). （Grant No.:MYRG2022-00020-ICMS）

药物分析学报（英文）

OACSCD

ISSN：2095-1779

访问量0

下载量0

段落导航